NVO Novo Nordisk

FRANKFURT--The following is a summary of analysts' forecasts for Novo Nordisk A/S (NVO) second-quarter results, based on a poll of seven analysts conducted by Dow Jones Newswires (figures in million danish kroner, EPS, dividend and target price in danish kroner, according to IFRS). Earnings figures are scheduled to be released August 5.

=== 
             Sales: 
                                              -NovoRapid/ 
2nd Quarter     -Total   -Victoza   -Levemir      NovoLog 
AVERAGE         28,291      5,001      4,569        5,202 
Prev. Year      27,059      4,486      4,522        5,230 
+/- in %          +4.6        +11       +1.0         -0.5 
 
MEDIAN          28,120      5,036      4,613        5,229 
Maximum         28,794      5,101      4,706        5,404 
Minimum         27,994      4,864      4,345        4,848 
Amount               7          7          7            7 
 
Baader-Helvea   28,756      5,058      4,706        5,330 
Berenberg       28,120      4,965      4,557        5,268 
Deutsche Bank   28,794      4,864      4,647        5,229 
Jefferies       28,118      5,048      4,440        5,212 
Morgan Stanley  28,229      5,036      4,673        5,404 
Nordea          27,994      5,101      4,345        4,848 
Swedbank        28,027      4,936      4,613        5,125 
 
             Operating                Net     EPS 
2nd Quarter     profit       PBT   income  diluted 
AVERAGE         12,501    12,532    9,884     3.89 
Prev. Year      12,482    10,548    8,343     3.23 
+/- in %          +0.2       +19      +18      +20 
 
MEDIAN          12,455    12,489    9,872     3.89 
Maximum         13,048    13,093   10,357     4.06 
Minimum         12,064    12,107    9,625     3.78 
Amount               7         6        7        7 
 
Baader-Helvea   13,048    13,093   10,357     4.06 
Berenberg       12,064    12,107    9,625     3.78 
Deutsche Bank   12,693    12,821   10,129     3.98 
Jefferies       12,495    12,498    9,873     3.89 
Morgan Stanley  12,403        --    9,687     3.82 
Nordea          12,455    12,480    9,872     3.89 
Swedbank        12,349    12,193    9,645     3.81 
 
          Target price  Rating                     DPS 2016 
AVERAGE         410.63  positive 4    AVERAGE          7.44 
Prev. Quarter   398.50  neutral  4    Prev. Year       6.40 
+/- in %         +3.04  negative 0    +/- in %          +16 
 
MEDIAN          402.50                MEDIAN           7.40 
Maximum         500.00                Maximum          7.72 
Minimum         375.00                Minimum          7.23 
Amount               8                Amount              4 
 
Baader-Helvea   425.00  Buy                              -- 
Berenberg       375.00  Hold                           7.23 
Citi            425.00  Buy                              -- 
Deutsche Bank   375.00  Hold                           7.72 
Jefferies       380.00  Hold                           7.29 
Morgan Stanley  430.00  Overweight                       -- 
Nordea          500.00  Buy                              -- 
Swedbank        375.00  Neutral                        7.50 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

(END) Dow Jones Newswires

August 02, 2016 08:00 ET (12:00 GMT)

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Aug 2024 to Sep 2024

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Sep 2023 to Sep 2024